The cis-polyisoprenoid lipids namely polyprenols, dolichols and their derivatives are linear polymers of several isoprene units. In eukaryotes, polyprenols and dolichols are synthesized as a mixture of four or more homologues of different length with one or two predominant species with sizes varying among organisms. Polyprenols have been hardly detectable in eukaryotic cells under normal conditions with the exception of plants and sporulating yeast. Our metabolomics studies revealed that cis-polyisoprenoids are more prevalent and diverse in the parasite Plasmodium falciparum than previously postulated as we uncovered active de novo biosynthesis and substantial levels of accumulation of polyprenols and dolichols of 15 to 19 isoprene units. A distinctive polyprenol and dolichol profile both within the intraerythrocytic asexual cycle and between asexual and gametocyte stages was also observed suggesting that cis-polyisoprenoid biosynthesis changes throughout parasite's development. In addition, we confirmed the presence of an active cisprenyltransferase (PfCPT) and that dolichol biosynthesis occurs via reduction of the polyprenol to dolichol by an active polyprenol reductase (PfPPRD) in the malaria parasite. Isotopic labeling and metabolomic analyses of a conditional mutant of PfCPT or PfPPRD suggest that polyprenols may be able to substitute dolichols in their biological functions when dolichol synthesis is impaired in Plasmodium.
The cis-polyisoprenoid lipids namely polyprenols, dolichols and their derivatives are linear polymers of several isoprene units. In eukaryotes, polyprenols and dolichols are synthesized as a mixture of four or more homologues of different length with one or two predominant species with sizes varying among organisms. Polyprenols have been hardly detectable in eukaryotic cells under normal conditions with the exception of plants and sporulating yeast. Our metabolomics studies revealed that cis-polyisoprenoids are more prevalent and diverse in the parasite Plasmodium falciparum than previously postulated as we uncovered active de novo biosynthesis and substantial levels of accumulation of polyprenols and dolichols of 15 to 19 isoprene units. A distinctive polyprenol and dolichol profile both within the intraerythrocytic asexual cycle and between asexual and gametocyte stages was also observed suggesting that cis-polyisoprenoid biosynthesis changes throughout parasite's development. In addition, we confirmed the presence of an active cisprenyltransferase (PfCPT) and that dolichol biosynthesis occurs via reduction of the polyprenol to dolichol by an active polyprenol reductase (PfPPRD) in the malaria parasite. Isotopic labeling and metabolomic analyses of a conditional mutant of PfCPT or PfPPRD suggest that polyprenols may be able to substitute dolichols in their biological functions when dolichol synthesis is impaired in Plasmodium.
Malaria is caused by protozoan parasites of the genus Plasmodium and most cases of lifethreatening malaria are attributable to infection with Plasmodium falciparum. The parasite has a complex life cycle that involves the human host and its vector, the Anopheles mosquitoes. All clinical features are caused during the asexual intraerythrocytic life cycle due to the repeated invasion of human red blood cells (RBCs). The asexual intraerythrocytic developmental cycle of P. falciparum lasts around 48 h, during which the parasite progresses through four morphologically different stages: ring, trophozoite, and schizont stages, ending with rupture of the erythrocyte and release of merozoites that will invade new erythrocytes. Transmission of the malaria parasite requires development of male and female gametocytes (gametocytogenesis), which are ingested by female mosquitoes during a blood meal and undergo sexual reproduction in the mosquito's midgut. Nondividing P. falciparum gametocytes take between 10 and 12 days to fully mature and progress through five morphologically distinct forms (stages I to V), which are different from other Plasmodium species.
During their complex life cycle malaria parasites encounter different nutritional environments within and between hosts. The presence of de novo and salvage pathways gives parasites a great metabolic flexibility to cope with those changes 1, 2 . For example, mature RBCs are capable of only a few metabolic functions since transcription and translation is not present in these cells. However, a wide variety of metabolites are available to the parasite in the human plasma 3 . Among the metabolic pathways that become inactive in mature RBCs is the mevalonate pathway which synthesizes the isoprenoid building blocks isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) 4 . Downstream de novo cis-polyisoprenoid biosynthesis of dolichols is also inactive in mature RBCs 5 but dolichols synthesized during erythropoiesis are still present in erythrocytes 6, 7 . On the other hand, P. falciparum has active isoprenoid biosynthesis during the asexual intraerythrocytic developmental cycle as well as during gametocytogenesis where the isoprenoid precursors IPP and DMAPP are synthesized through the methylerythritol phosphate (MEP) pathway [8] [9] [10] .
The MEP pathway is localized in the apicoplast 11, 12 , a unique chloroplast-like organelle essential for growth and pathogenesis of the malaria parasite 13 (Fig. 1) . Moreover, supply of the isoprenoid precursor IPP is the sole metabolic function of the apicoplast in asexual intraerythrocytic cycle and gametocyte stages 10, 14 . The fact that exogenous supply of IPP alone allows parasites lacking the apicoplast to normally grow and develop indicates that IPP is transported out of the apicoplast where the synthesis of cis-polyisoprenoid products is predicted to occur ( Fig. 1) 10, 14 . cis-Polyisoprenoids (polyprenols, dolichols and their phosphate esters and carboxylic acid derivatives) are linear polymers of several isoprene units. These lipids are present in all membrane systems 15, 16 but their biological functions besides protein glycosylation in the ER remains largely unknown. Recently, cis-polyisoprenoids gained special attention due to several breakthroughs in the field including improvements in the analytical techniques for their analysis 17, 18 , partial identification of their enzymatic machinery 19 , and the discovery of new biological functions beyond glycosylation 20, 21 . Among some of these biological functions are the regulation of the membrane fluidity 21 , stimulation of spore wall formation in yeast 20 , and scavenging free radicals in cell membranes [22] [23] [24] . Interestingly, in cancer cells 25 and P. falciparum 26 , protein dolichylation occurs as a post-translational event, but functions of such derivatives and enzymes involved in this posttranslational protein lipid modification remain unknown.
cis-Polyisoprenoid metabolism and its biological functions in P. falciparum remain poorly understood. The initial step of cis-polyisoprenoid de novo biosynthesis in the malaria parasite is common to all isoprenoid products ( Fig. 1 ) where a multifunctional enzyme synthesizes farnesyl diphosphate (FPP) and geranylgeranyl diphosphate (GGPP) 27 . Synthesis of cis-polyprenyl diphosphate (PDP) is then proposed to be catalyzed by a cis-prenyltransferase (CPT) which adds several IPP molecules in cisconfiguration to FPP or GGPP. This step is called elongation and in animals occurs in the endoplasmic reticulum (ER) where its downstream products dolichyl phosphates (Dol-Ps) serve as lipid oligosaccharide carrier for protein N-glycosylation, C-and O-mannosylation and glycosylphosphatidylinositol (GPI) synthesis (reviewed in 28 ). In other organisms, cis-polyisoprenoid synthesis also occurs in peroxisomes (rat 29 , yeast 30 ), lipid droplets (yeast 20, 31 ) and chloroplasts (plants, cyanobacteria 21, 32 ). The postulated final steps of cis-polyisoprenoid biosynthesis involve dephosphorylation of PDP to polyprenol followed by reduction of the a-isoprene unit by polyprenol reductase (PPRD), also called SRD5A3 or DFG10 in mammals and yeast, respectively ( Fig. 1 ). Whether dephosphorylation of PDP is catalyzed by one or two enzymes 33 has not been elucidated in any organism. Moreover, it has also been suggested that an isopentenol or isopentanol, instead of IPP, is added at the last step, which would avoid the need of dephosphorylation or dephosphorylation and reduction, respectively, but it remains to be addressed 15, 34 .
In eukaryotes, dolichols and polyprenols are synthesized as a mixture of four or more different lengths indicated by the total number of carbons or IPP units, e.g. polyprenol/dolichol 11 or C55, with one or two predominant species (isoprenologues) where the size varies among organisms. Interestingly, polyprenols are hardly detectable in eukaryotic cells under normal conditions with the exception of plants and sporulating yeast. In the malaria parasite, cis-polyisoprenoid biosynthesis has received little attention because the relevance of glycosylation in Plasmodium was unclear until recently 28 , and a previous report established that the malaria parasite synthesizes dolichols of 11 and 12 isoprene units 35 . However, our preliminary untargeted lipidomic analyses using liquid chromatography combined with high-resolution mass spectrometry (LC-HRMS) system revealed co-occurrence of polyprenols and dolichols which steered us to reexamine cis-polyisoprenoid biosynthesis in P. falciparum. Further metabolomics and molecular studies revealed that cis-polyisoprenoids are more prevalent and diverse than previously postulated. We uncovered active biosynthesis of medium-long polyprenols and dolichols (15 to 19 isoprene units). Moreover, a distinctive profile of polyprenols and dolichols was observed both within the asexual intraerythrocytic cycle and between asexual and gametocyte stages suggesting that their biosynthesis changes throughout parasite's development. In addition, we confirmed that dolichol biosynthesis occurs via an active PfCPT (PF3D7_0826400) and reduction of the polyprenol to dolichol by PfPPRD (PF3D7_1455900). Two recent functional profiling studies of the Plasmodium genome indicate that PfPPRD and PfCPT are predicted to be essential 36, 37 . We were able to obtain transgenic strains for inducible knockdown (KD) of PfCPT or PfPPRD but a lethal or severe growth defect phenotype was not observed in both transgenic strains. De novo dolichol biosynthesis was still present in the PfCPT knockdown mutants suggesting that some protein expression is still present, thus, explaining the lack of growth defects despite the lower levels of polyprenols and dolichols as compared to controls. However, de novo dolichol biosynthesis was undetectable in the PfPPRD knockdown mutant and a pronounced increased in polyprenol levels was observed. This observation together with the lack of a severe growth defect phenotype suggests that polyprenols may be able to substitute dolichols in their biological functions when dolichol synthesis is impaired.
Results

Medium-long polyprenols and dolichols are present in the asexual and sexual intraerythrocytic stages of P. falciparum
Biosynthesis of dolichol composed of 11 and 12 isoprene units in the schizont stage of malaria parasites has been assessed previously using radiolabeled metabolic precursors followed by thin layer chromatography (TLC) and high-performance liquid chromatography (HPLC) analysis 35 as well as by purifying unlabeled metabolites by HPLC followed by mass spectrometry (MS) analysis of each fraction 38 . Modulation of dolichol chain length upon a particular physiological condition has been observed earlier. For example, shorter isoprenologues are found in actively dividing cells such as cancer cells compared to not actively dividing cells 39, 40 . Thus, we hypothesized that a similar scenario may occur between actively diving asexual stages and nondividing gametocyte stages of P. falciparum. To assess this hypothesis, we performed metabolomics analysis by LC-HRMS as we described previously 41 . In the asexual schizont stage, we detected the presence of both polyprenols and dolichols of 15 to 19 isoprene units with isoprenologues 15, 16 and 17 being the predominant species ( Fig. 2a ) while in stage IV gametocytes dolichols of 15 to 20 isoprene units were also present, but the predominant species were dolichols of 17, 18, 19 isoprene units ( Fig. 2b ). Under our experimental conditions, polyprenols were almost undetectable in gametocytes. As expected, human RBCs contain low levels of dolichols of 18 to 20 isoprene units with 19 being the predominant isoprenologue ( Fig. 2c ). This is the first time that the cispolyisoprenoid profile is determined by LC-HRMS in P. falciparum, and under our experimental conditions, dolichols and polyprenols of 11 and 12 isoprene units were not detected probably due to their low abundance. To our knowledge, this is also the first time that detectable levels of polyprenols and cooccurrence of polyprenols and dolichols are reported to be present in any other eukaryotic cell besides plants and sporulating yeast. Interestingly, a distinctive temporal profile of polyprenols and dolichols in the asexual intraerythrocytic developmental cycle of P. falciparum was also observed. In schizont stages, dolichol/polyprenol ratios were closer to one except for dolichol 15 while ring and trophozoite stages presented considerably higher ratios than schizonts (Table 1) .
Medium-long polyprenols and dolichols are synthesized de novo by P. falciparum
In order to confirm that the detected polyprenols and dolichols were in fact synthesized by the parasite, de novo biosynthesis was assessed by metabolic labeling using [1-13 C]glucose or [3-13 C]IPP ( Fig. 3a ). The specific labeling pattern of isoprene units resulting from glucose metabolism via glycolysis and incorporation through the mevalonate and MEP pathway are well established 17, 18 . Because both the mevalonate and dolichol pathway are inactive in human RBCs 4 , only MEP pathway-specific labeling patterns are observed in P. falciparum infected RBCs 4,8,9 . Highly synchronous infected RBCs in ring stage at 7% parasitemia were first incubated in glucose-free media for 2 h and then supplemented for 24 h with [1-13 C]glucose (4 g/L) which is known to be metabolized into [1, [5] [6] [7] [8] [9] [10] [11] [12] [13] C]IPP ( Fig. 3a) . A similar scheme was used for the metabolic precursor [3-13 C]IPP, but in this case cultures were treated for 2 h with 10 µM fosmidomycin (FOS), an inhibitor of 1deoxy-D-xylulose 5-phosphate reductoisomerase (DXR) -a key enzyme of the MEP pathway ( Fig. 1) 8, 12 , to reduce >75% the endogenous IPP pool as we reported previously 42 , therefore, favoring the uptake of exogenous IPP. Then, cultures were supplemented with a mixture of [3-13 C]IPP and unlabeled IPP (1:1) at 200 µM final concentration in the presence of FOS. It is well established that 200 µM of exogenous IPP is necessary to reverse growth inhibition caused by FOS or the absence of the apicoplast 10, 14, [42] [43] [44] . During optimization of the 13 C-biolabeling experimental design, we established that parasites required at least 20-24 h of growth in the presence of the 13 C-precursor starting at ring stage in order to observe 13 Cenrichment in polyprenols and dolichols (data not shown). As previously described by Swiezewska and colleagues 17, 18 , 13 C-enrichment in polyprenols and dolichols was observed as a Gaussian distribution of isotopologues for each of the 13 C-precursors ( Fig. 3b , Supplementary Fig. S1 ). The m/z shift toward higher molecular mass mirrors the stochastic distribution of the probability of incorporating differentially labeled 13 C-IPP into 13 C-polyprenols, and therefore 13 C-dolichols, which is determined by the remaining pool of native metabolic precursors in the cell that contain a 13 C natural abundance of ~1% and the number of 13 C-atoms incorporated into IPP based on the isotopic dilution due to metabolism 17, 45 . As shown in Fig. 3a , the probability of [1-13 C]glucose to potentially label each of the carbon atoms C-1 and C-5 of IPP is around 0.5, thus, it is expected that the m/z shift of the Gaussian distribution will center around [M+(n)] with n being the number of isoprene units in the polyprenol or dolichol detected as the ammonium adduct. In the case of [3-13 C]IPP, the m/z shift of the Gaussian distribution will center around [M+(1/2 n)] of the ammonium adduct because cultures were supplemented with a mixture of [3-13 C]IPP and IPP (that contains a 13 C natural abundance of ~1%) at the 1:1 molar ratio to reach the 200 µM final concentration necessary to fully rescue FOS inhibition as previously reported 14 . As expected, only unlabeled dolichols were detected in uninfected RBCs since there is no active de novo biosynthesis of isoprenoids ( Fig. 3c , Supplementary Fig. S1 ). Altogether, these results confirmed that the detected polyprenols and dolichols of 15 to 19 isoprene units are exclusively biosynthesized by the malaria parasite.
It has been demonstrated that P. falciparum stage III gametocytes incorporate and metabolize 13 C-glucose 46 . In addition, we previously reported that the MEP pathway intermediates are present in late-stage gametocytes and that IPP synthesis is essential for normal gametocytogenesis since gametocytes lacking the apicoplast require exogenous IPP supplementation until they reach stage IV 10 . Surprisingly, 13 C-enrichment in dolichols was not detected in stage IV gametocytes when [1-13 C]glucose was supplemented starting at stage III ( Fig. 4 ). Therefore, these results suggest that synthesis of dolichols occurs earlier than stage III during gametocytogenesis and that IPP is required for other isoprenoid products than dolichols in gametocyte stages III to IV 10 .
P. falciparum polyprenol reductase restored glycosylation of mCPY and reduced polyprenols levels in yeast dfg10D D mutant cells
We hypothesized that presence of polyprenols in P. falciparum indicates that dolichol biosynthesis may occur via reduction of the polyprenol to dolichol by an active PfPPRD (PF3D7_1455900) ( Fig. 1) . Therefore, the coding sequence of the putative PfPPRD was optimized for codon usage in yeast and its enzymatic function was confirmed by complementation assays in Saccharomyces cerevisiae. It was previously reported by Cantagrel and colleagues 47 that human PPRD (SRD5A3) can complement the N-glycosylation defects caused by an inactive yeast DFG10, which is the PPRD in this organism for dolichol biosynthesis. As mentioned above, their downstream products Dol-P serve as lipid linked oligosaccharide carrier for protein glycosylation (Fig. 1 ). In this work, we used the dfg10D mutant cells where the DFG10 gene is deleted from the chromosome and displays a lack of Nglycosylation. Mature carboxypeptidase Y (mCPY) has four N-glycosylation sites which are all occupied under normal growth conditions in yeast 48 and depend on a functional PPRD/DFG10 (Fig. 5a) 47 . A single band of fully glycosylated mCPY was observed in wild-type (WT) cells when mCPY is fully glycosylated while four extra bands were detected in dfg10D mutant cells representing the different glycoforms (-1, -2, -3, -4) (Fig. 5a , lane 2). The mutant transformed with yeast DGF10 or PfPPRD under the control of the endogenous DFG10 promoter showed full correction of the CPY underglycosylation. Some underglycosylated CPY was still detected in cells expressing PfPPRD, suggesting that this enzyme was not as active as yeast DFG10.
In order to confirm the biochemical effects underlying the yeast complementation, we assessed the profile of polyprenols and dolichols by LC-HRMS ( Fig. 5b ). As described previously 5, 47 , only dolichol 15 and 16 were detected in WT yeast while polyprenols along with dolichols were detected in the dfg10D mutant cells. As expected, dfg10D mutant cells expressing PfPPRD showed reduction of the polyprenol levels confirming its predicted enzymatic function (polyprenol ® dolichol).
Modification of the CPT and PPRD locus in P. falciparum
Two recent functional profiling studies of the Plasmodium genome indicate that Plasmodium PPRD and CPT are predicted to be essential 36, 37 . Thus, in order to gain insight into the polyprenol and dolichol biosynthesis in P. falciparum, we used the CRISPR/Cas9 with the tetracycline repressor (TetR) and development of zygote inhibited (DOZI) fusion protein to generate a TetR-DOZI inducible knockdown (KD) mutant strain 49 of PfCPT or PfPPRD (Fig. 6a ). We successfully modified the PfPPRD genomic locus of 3D7 strain (Fig. 6b ). We attempted to generate a C-terminus triple-human influenza hemagglutinin (HA) tagged PfPPRD to assess its localization but multiple attempts with this construct failed ( Supplementary Fig. S2 ) suggesting that PfPPRD tagged at the C-terminus is not efficiently translated or the protein is unstable. It is also possible that the highly conserved catalytic domain of PfPPRD is located in the C-terminal as predicted for the human and plant orthologs 47, 50 and tagging interferes with proper enzymatic function. On the other hand, we were able to generate a C-terminus triple-HA tagged PfCPT in 3D7 strain ( Fig. 6b ). Both P. falciparum transgenic strains were subjected to clonal selection and genomic modifications were confirmed by DNA sequencing.
Characterization of PfPPRD and PfCPT conditional knockdowns
The untagged conditional KD system of PfPPRD (PfPPRD-TetR-DOZI) was induced by removing anhydrotetracycline (aTc), which relieves translational repression by the TetR-DOZI complex 49 (Fig. 7a ). Interestingly, morphological defects and a slight but significant growth defect were observed only after 8 days (5 th intraerythrocytic life cycle) without aTc ( Fig. 7b ). We were not able to obtain a PfPPRD-HA-TetR-DOZI strain ( Supplementary Fig. S2 ), thus, it was not possible to determine whether the observed growth and morphological defects were attributed to a gradual or incomplete reduction in PfPPRD protein levels as this enzyme is predicted to be essential 37 . However, the levels of polyprenols and dolichols were determined by LC-HRMS to assess whether PfPPRD enzymatic activity was reduced in the absence of aTc confirming that PfPPRD synthesizes dolichols in vivo. Metabolomics analyses were performed in trophozoite stage parasites where the highest dolichol/polyprenol ratios are observed due to low levels of detectable polyprenols (Table 1 ). In the absence of aTc for 3 days, parasites displayed a pronounced accumulation of polyprenols 15 to 18 and a slight reduction of dolichols 15 to 17 without changes in the levels of dolichol of 18 to 20 isoprene units suggesting that some residual PfPPRD activity may still be present (Fig. 7c) . Surprisingly, after 10 days of aTc removal a similar pronounced accumulation of polyprenols 15 to 18 was observed but dolichols 15 to 17 were undetectable while dolichols 18 to 20 were not significantly reduced (Fig. 7d) .
In order to assess if the detected dolichols of 18 to 20 isoprene units were de novo biosynthesized by parasites, we performed metabolic labeling with [1-13 C] glucose in cultures after 10 days of aTc removal. 13 C-Enrichment was observed in polyprenol 18 but not in dolichols 18 to 20 suggesting that the detected dolichols in cultures after 10 days of aTc removal were not synthesized de novo by parasites ( Fig. 8, Supplementary Fig. S3 ). Consistent with our results shown in Table 1 , polyprenol 19 was undetectable in trophozoite stage both with and without aTc supplementation. Dolichols of 18 to 20 isoprene units are present in uninfected RBCs (Fig. 2c ) and the treatment with saponin used to isolate whole infected erythrocytes depleted of hemoglobin does not separate the host erythrocyte membrane from the parasite 51 (see materials and methods). Therefore, we cannot rule out that the detected dolichols of 18 to 20 isoprene units are those present in the erythrocyte membrane, which their detection became more prevalent in the absence of biosynthesis by parasites. Thus, it is possible that the lack of severe growth defect observed in the PfPPRD mutant is due to polyprenols performing the biological functions of dolichols in P. falciparum.
To further investigate if lack of polyprenols may be essential for the malaria asexual intraerythrocytic developmental cycle, we performed the same analyses using the conditional KD system of PfCPT-HA-TetR-DOZI. Parasites maintained in the presence of aTc displayed both normal growth and morphology with active cis-polyisoprenoid biosynthesis ( Fig. 9 ) supporting that presence of a C-terminal triple HA tag does not affect PfCPT function. Removal of aTc for 6 days was not lethal but a striking reduction of polyprenols 15 to 18 and dolichols 15 to 19 was observed confirming the enzymatic function of PfCPT in vivo and suggesting that some residual PfCPT activity may still be present in the conditional KD allowing parasites to grow normally as this enzyme is also predicted to be essential 37 . Interestingly, PfCPT-KD ( Fig. 9a ) phenocopied PfPPRD-KD ( Fig. 7d ) since dolichols of 18 to 20 isoprene units became the predominant species after several days of aTc removal. We also performed principal component analysis (PCA) where results are displayed as score plots, and each point represents a sample that when clustered together indicates similar metabolite composition based on the metabolomic analysis performed, which in this case was for nonpolar lipids including polyisoprenoids present in the hexane fraction. As expected, a significant change in the parasite metabolome was observed in the absence of aTc (Fig. 9b ). As mentioned above, we confirmed the presence of the triple HA tag by DNA sequencing, however, PfCPT-HA could not be detected by western blot, but it was detected by immunofluorescence microscopy (IFA) suggesting low expression ( Fig. 9d ). Interestingly, strong colocalization of PfCPT-HA with the ER marker PfBiP 52 was observed in ring stage, but colocalization became very weak in schizont stage suggesting that PfCPT subcellular localization changes with development and that cispolyisoprenoid biosynthesis potentially may occur outside the ER. Expression of PfCPT-HA was faintly detected in parasites after 6 days of aTc removal (Fig. 9d ) further supporting our metabolomics analysis suggesting presence of residual PfCPT activity (Fig. 9a ).
PfCPT and PfPPRD knockdowns have normal MSP1 localization
One of the main known biological functions of dolichols is their role in the synthesis of GPI. The merozoite surface protein 1 (MSP1) is a well-studied GPI-anchored protein uniformly distributed in the parasite plasma membrane and a highly abundant ligand coating the merozoite surface 53 . MSP1 plays a role not only during invasion of RBCs but also during parasite's egress and it is predicted to be essential 37, 53 . Previously, using an inducible Cre recombinase-mediated excision system, it was shown that a truncated MSP1 that lacked a GPI anchor is trafficked to the parasitophorous vacuole but is not attached to the merozoite plasma membrane showing a punctuate localization rather than a uniform distribution 53 . Moreover, these mutants presented a substantially reduced replication rate 53 . Because both PfPPRD-KD and PfCPT-HA-KD presented an altered polyprenol and dolichol profile without a lethal or severe growth defect phenotype, we hypothesized both mutants are able to still carry out protein glycosylation. Therefore, we assessed the localization of MSP1 in PfPPRD-KD and PfCPT-HA-KD by IFA ( Fig. 10 ). As expected, MSP1 showed normal localization as previously reported 53 in the presence of aTc and no differences were observed in both mutants compared to controls after 10 days of aTc removal suggesting that posttranslational GPI modifications are not affected. Altogether, our results reported here suggest that polyprenols may substitute dolichols as a lipid-linked sugar donor for glycosylation in P. falciparum which may explain the lack of a severe growth defect in the PfPPRD mutant and guarantees further investigation.
Discussion
Our studies using 13 C-profiling by LC-HRMS uncovered for the first time in P. falciparum cooccurrence of polyprenols and dolichols as well as synthesis of longer dolichol species than previously reported. The presence of a distinctive polyprenol and dolichol profile within the intraerythrocytic asexual cycle and between asexual and gametocyte stages suggest that cis-polyisoprenoid biosynthesis changes throughout parasite's development. Interestingly, in mammals and plants increased level of polyprenol/dolichol ratio results in aberrant glycosylation with shorter glycans 54 . However, it is difficult to assess if a similar response occurs in the malaria parasite since it has been shown that Plasmodium synthesizes very short N-glycans 28, 55 . cis-Polyisoprenoid lipids are present in all membrane systems 15, 16 but their biological functions besides protein glycosylation in the ER remain largely unknown. A recent fluorescence anisotropy analysis performed in the protein-dense thylakoid membranes of the chloroplast, revealed that membrane areas with less polyprenols had greater membrane fluidity and photosynthesis was affected 21 . These analyses together with numerous in vitro studies employing model membranes 5 suggest that polyprenols affect the biophysical characteristics of biological membranes. Moreover, it was recently demonstrated in yeast that lipid droplets of vegetative cells contain mainly dolichols of 14 to 17 isoprene units while sporulating cells not only shift toward longer dolichol species (19 to 24 isoprene units) but also accumulate similar levels of polyprenols of 19 to 24 isoprene units. Long-chain polyprenols synthetized by a developmentally regulated CPT present in lipid droplets (Srt1) promote spore wall formation by serving as a signal that activates chitin synthase (directly or indirectly which remains to be determined) possibly through changes in the membrane structure introduced by polyprenols 20 . Therefore, it is possible that the changes in the size of polyisoprene chain and levels of co-occurrence of polyprenols and dolichols during the intraerythrocytic life cycle and gametocyte stages may be associated with their participation in other cellular processes beside glycosylation which guarantees further investigation.
The presence of polyprenols in P. falciparum supports that dolichol biosynthesis occurs via reduction of the polyprenol to dolichol and we confirmed that this step is catalyzed by PfPPRD (PF3D7_1455900) which is predicted to be essential in blood stages 37 . Intriguingly, our PfPPRD mutant strain revealed that after aTc has been removed for several days, shorter dolichols were undetectable while dolichols of 18 to 19 isoprene units were still present but not synthesized de novo. Due to limitations of current tools to study cis-polyisoprenoids metabolism and their biological functions as well as in the approaches to separate parasites from its host erythrocyte membrane, it cannot be rule out that the detected dolichols of 18 to 20 isoprene units are in fact present in the erythrocyte membrane and are not internalized by the parasite. Interestingly, PfPPRD knockdown mutant was not lethal but after at least 8 days of aTc removal a slight but significant growth defect as well as abnormal parasites were observed. Metabolomics analysis revealed that polyprenols were drastically increased in the PfPPRD knockdown mutants. As mentioned above, numerous in vitro studies employing model membranes 5 suggest that polyprenols affect the biophysical characteristics of biological membranes. Therefore, it is also possible that the high levels of polyprenols detected in the absence of aTc may have affected membranes and their functions, thus, contributing to the slight growth and morphological defects observed. In addition, it cannot be ruled out that polyprenols may be able to perform some of the functions of dolichols when their synthesis is compromised including glycosylation as it has been previously suggested to occur in fibroblasts from patients carrying a homozygous SRD5A3 mutation, the human orthologue of PfPPRD 54 as well as in Chinese hamster ovary cells 56, 57 . The efficiency of glycosylation by polyprenols in mammalian cells seems to be lower compared to dolichols and detrimental for cells 54 . Therefore, it is possible that a similar scenario is occurring in the PfPPRD mutants which may also contribute to the slight growth defect observed. However, we did not observed differences in the localization of MSP1 in the PfCPT and PfPPRD knockdown strains when compared to controls suggesting that GPI biosynthesis is not affected in these mutants. As mentioned above, MSP1 lacking a GPI anchor is trafficked to the parasitophorous vacuole but is not attached to the merozoite plasma membrane showing a punctuate localization rather than uniform distribution as we observed in our studies 53 . In the case of the PfPPRD mutant, normal localization of MSP1 suggests that polyprenols may be able to carry out glycosylation in the absence of dolichols ( Fig. 7 and 10) , if the dolichols of 18 to 19 isoprene units detected in the absence of aTc are localized in the erythrocyte membrane and are not internalized by the parasite. On the other hand, normal localization of MSP1 in the PfCPT may be explained by the fact that the knockdown system used was unable to completely eliminate polyprenol biosynthesis suggesting that parasites can carry out normal glycosylation with low levels of dolichols ( Fig. 9 and 10) . Currently, we are attempting to generate an inducible knockout of PfCPT to further verify its predicted essentiality 37 . Nevertheless, further investigations are needed to verify that polyprenols can be phosphorylated and glycosylated as dolichols in the malaria parasite.
As a result of several breakthroughs in the field of cis-polyisoprenoids 17, 19, 20 , new biological functions of these lipids are starting to be unveiled besides their known role in protein glycosylation. Further studies are still needed to answer why co-occurrence of polyprenols and dolichols is present in the malaria parasite as well as why cis-polyisoprenoid species change during the parasite's life cycle which may reveal new biological functions of these unique lipids.
Materials and Methods
Chemicals
The isotopically labeled intermediate [1-13 C] glucose (99% isotopic abundance) was obtained from Cambridge Isotope Laboratories Inc (Tewksbury, MA, USA). 
Stable isotope labeling of P. falciparum-infected and uninfected RBCs for polyisoprenoids profiling
Mycoplasma-free parasite cultures were tightly synchronized by two consecutive treatments with 5% sorbitol (Millipore-Sigma, Burlington, MA, USA). Each biological replicate was obtained from 75 mL of P. falciparum-infected RBC cultures at 5% hematocrit and 7% parasitemia. For stage-specific polyisoprenoid profiling, parasites in trophozoite and schizont stages were obtained from P. falciparuminfected RBC cultures starting with early ring stage at 7% parasitemia and harvesting parasites at each indicated stage. Parasites at ring stage were obtained from synchronized cultures starting with early rings of P. falciparum at 3% parasitemia and recovering parasites after 48 h incubation to avoid collecting cells after sorbitol treatment.
For metabolic labeling experiments using [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] In order to assess dolichol and polyprenol profiles in trophozoite stage of the PfPPRD or PfCPT conditional knockdowns, parasites were grown in media supplemented either with 2.5 µg/mL Blasticidin S and 0.5 µM aTc, or only 2.5 µg/mL Blasticidin S for the indicated times ( Fig. 7 and 9 ). 13 C-Biolabeling experiments were performed under similar conditions to induce the knockdown and then metabolically labeled as described above.
In all cases, infected RBCs were treated with 0.03% saponin in cold phosphate-buffered saline (PBS) solution containing 2 g/L glucose and washed three times with PBS/glucose by centrifuging 7 min at 10,000 × g at 4 o C. Ten µL were collected in the last wash to count parasites using a Countess cell counter (Thermo Fisher Scientific, Waltham, MA, USA). Cell pellets were flash-frozen and stored at -80°C until metabolite extractions were performed.
Gametocyte stages were obtained using P. falciparum NF54 strain grown in human pooled serum (Interstate Blood Bank, TN, USA) to a final concentration of 10%. Briefly, highly synchronous cultures at early ring stage were obtained by sorbitol treatment, purified using a MACS Ò magnetic affinity column (day 0) and set at 8-12% parasitemia and 5% hematocrit. On day 0 and 1, gametocytogenesis was induced by incubating cultures with 50% spent media and 50% fresh media for 40-48 h, as described previously 58 . After reinvasion, asexual parasites were depleted from culture by addition of fresh media containing 20 U/mL of heparin for 4 days (day 2 to 5) and sorbitol treatment 59 . After day 5, the media was replaced every two days until gametocytes reached stage IV. Development of parasites was monitored by microscopic evaluation of Giemsa-stained thin smears. For metabolic labeling experiments, stage III gametocyte cultures where obtained as described above (day 6 after induction). Then, parasites were incubated in glucose-free media for 2 h before adding [1-13 C]glucose (4 g/L) and incubated for 24 h when media was changed to add fresh [1-13 C]glucose (4 g/L) and to complete a total of 48 h labeling until gametocytes reached stage IV.
Sample preparation and polyisoprenoid profiling by LC-HRMS
Extraction of metabolites and LC-HRMS analysis was performed as we previously described 41 . Briefly, 1 mL cold methanol was added to each sample and three consecutive extractions with 2 mL of hexane followed by pulse-vortex for 1 min and 10 min sonication in an ultrasonic bath. The upper phases were combined, dried under nitrogen and stored at -80°C until LC-HRMS analysis. For LC-HRMS analysis, samples were resuspended in 100 µL of methanol/acetonitrile/2-propanol (60:25:15, v/v) pulse vortex 5 times and sonicate for 10 min. Analysis of polyisoprenoids was performed on an ionKey/MS system composed of an ACQUITY UPLC M-Class, the ionKey source, and an iKey HSS T3, 100 Å, 1.8 µm (particle size), 150 µm × 100 mm column coupled to a SYNAPT G2-Si mass spectrometer (Waters Corporation, Milford, MA, USA). Isoprenoid separation was accomplished as described previously 41 and a representative extracted ion chromatogram is shown in Supplementary Fig. S4 . For unlabeled samples, peak identification, alignment, normalization, and statistical treatment of the data was performed using Progenesis QI software (Nonlinear Dynamics, Waters Corporation, Milford, MA, USA). For 13 Cbiolabeled samples, MassLynx software (Waters Corporation, Milford, MA, USA) was used for data processing and 13 C-labeling distribution analysis. The area of the analyte (metabolite) peak was normalized to the cell number and the response of each detected metabolite is expressed as the mean and s.e.m. of at least three independent biological replicates.
Heterologous expression of PfPPRD and analysis of CPY glycosylation in Saccharomyces cerevisiae transformants
HA-tagged DFG10 and PfPPRD (optimized for codon usage in yeast) were expressed under the control of the DFG10 endogenous promoter from a centromeric plasmid, pRS416. Empty vector pRS416 was included as a negative control. Saccharomyces cerevisiae strain BY4741 (MATa his3D1 leu2Δ met15Δ ura3Δ) and BY4741-based dfg10Δ strains were grown at 30°C in synthetic complete (SC) medium containing 2% galactose as the carbon source 60 . Uracil was omitted from the medium to maintain the plasmid. After two passages (36 to 48 h) in SC medium, cells were harvested when the optical density at 600 nm (OD600) reached between 0.4 and 1.0. Two OD600 units of cells were harvest for protein analysis and 25 OD600 units of cells were harvested for analysis of polyisoprenoids by LC-HRMS.
Total proteins were extracted as described previously 61 . Equal amount of proteins was analyzed using a 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a polyvinylidene difluoride (PVDF) membrane. Mouse anti-CPY (1:5,000; Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) was used as the primary antibody; horseradish peroxidase (HRP)conjugated anti-mouse antibody (1:5,000 dilution; Thermo Fisher Scientific, Waltham, MA, USA) together with the Supersignal West Femto substrate (Thermo Fisher Scientific, Waltham, MA, USA) were used to detect the target protein.
Generation of a P. falciparum strain with an inducible knockdown of PfPPRD or PfCPT
Genomic DNA was isolated from P. falciparum 3D7 strain and homology regions were PCR amplified using PrimeStar GXL DNA polymerase (Takara Bio Inc., Mountain View, CA, USA). The 3'untranslated homology region (3'-UTR) was amplified using forward P1 and reverse P2 primers ( Supplementary Table S1 ). The C-terminal homology region was amplified using forward primer P3 and reverse primer with triple-hemagglutinin (HA) tag P4 or without HA tag P5. The 3'-UTR and C-terminal homology regions were combined using forward P1, reverse P4 or P5 primers and PrimeStar GXL DNA polymerase (Takara Bio Inc., Mountain View, CA, USA). The resulted PCR product was cloned into TetR-DOZI plasmid 49 by sequence-and ligation-independent cloning (SLIC) using T4 DNA polymerase (Thermo Fisher Scientific, Waltham, MA, USA) as previously described 62 . Before transfection, PfPPRD-HA-TetR-DOZI and PfPPRD-TetR-DOZI plasmids were linearized with EcoRV (New England BioLabs, Ipswich, MA, USA). The RNA guide (gRNA) sequence was chosen using ChopChop online platform (http://chopchop.cbu.uib.no/). Primers forward P6 and reverse P7 were annealed and inserted into pUF1-Cas9-guide 63 as previously described 64 . Briefly, pUF1-Cas9-guide was digested with BtgZI and annealed oligos were inserted using the SLIC method.
The same approach described above was used to generate a conditional knockdown of PfCPT. Briefly, the 3'-UTR region was amplified using primers forward P10 and reverse P11. The C-terminal homology region was amplified using primers forward P12 and reverse with or without HA tag P13 and P14, respectively. After combination of the homology regions, SLIC and cloning, PfCPT-HA-TetR-DOZI and PfCPT-TetR-DOZI products were linearized for transfection using HPaI (New England BioLabs, Ipswich, MA, USA). Primers forward P15 and reverse 16 were used for annealing and insertion of the guide RNA into pUF1 vector previously digested.
Twenty µg of each linearized plasmid was mixed with 60 µg of pUF1-Cas9-guide and precipitated. DNA pellet was dissolved in Cytomix Buffer 49 and combined with fresh red blood cells (RBCs). The DNA/RBC mixture was electroporated using BioRad Gene Pulser Xcell TM system at 0.32 kV and 925 µF. A culture of P. falciparum in schizont stage at 10-15% parasitemia was added to the RBCs and parasites were grown in the presence of 0.5 µM aTc (Cayman Chemical, Ann Arbor, MI, USA). Drug pressure was applied 48 hours post-transfection using 2.5 µg/mL Blasticidin S (BSD) (Millipore-Sigma, Burlington, MA, USA). Media was changed daily for the first 7 days and every other day thereafter. P. falciparum cultures were split 1:1 every 7 days to provide fresh uninfected RBCs and to perform DNA extraction for integration analysis.
Growth and morphological assessment of the PfPPRD-TetR-DOZI and PfCPT-HA-TetR-DOZI
In order to assess potential morphological defects due to the reduced expression of PfPPRD and PfCPT, P. falciparum cultures treated with BSD only or BSD+aTc as indicated above were monitored by Giemsa-stained smears every 24 h for over 8 days. Potential growth defects were assessed by seeding cultures in a 96 well plate (0.5% early trophozoite stages at 4% hematocrit) and treated with BSD only or BSD+aTc with each condition tested in triplicate. Throughout the course of the experiment, parasites were sub-cultured to maintain the parasitemia between 1-5%. Parasitemia was monitored every 24 hours by flow cytometry using a CytoFLEX S (Beckman Coulter, Hialeah, FL, USA). A sample of 0.5 µL from each well was stained with Hoechst (Thermo Fisher Scientific, Waltham, MA, USA) at 0.8 µg/mL in PBS and data were analyzed using Prism (GraphPad Software, Inc.). Relative parasitemia at each time point was back calculated based on actual parasitemia multiplied by the relevant dilution factors.
Statistical analysis
The t-test and Benjamini and Hochberg procedure were used to analyze differences between different conditions, and a false discovery rate of 0.01 was used to identify statistically significant differences.
Fluorescence microscopy
Cells were fixed using a mixture of 4% paraformaldehyde and 0.015% glutaraldehyde and permeabilized with 0.1% Triton-X100 as described previously 62 . Primary antibodies used for IFAs in this study were the following: mouse anti-MSP1 antibody (European Malaria Reagent Repository, 1:500), rat anti-PfBiP MRA-1247 (BEI Resources, NIAID, NIH, 1:100) and mouse anti-HA(6E2) (Cell Signaling Technology Inc., 1:100). Anti-mouse and anti-rat antibody conjugated to Alexa Fluor 488 or Alexa Fluor 546 (1:100, Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) were used as secondary antibodies. Cells were mounted on ProLong Gold with 4',6'-diamidino-2-phenylindole (DAPI) (Thermo Fisher Scientific, Waltham, MA, USA) and imaged using a Delta-Vision II microscope system with an Olympus IX-71 inverted microscope using a 100x objective A. Image processing, analysis and display were preformed using SoftWorx and Adobe Photoshop. Adjustments to brightness and contrast were made for display purposes. promotes a double-stranded break in the genomic locus while the repair plasmid provides a homology region at the C-terminus of PfPPRD or PfCPT (target-C-t) for double crossover homologous recombination to introduce a 3′-untranslated region (UTR) RNA aptamer sequence that binds a tetracycline repressor (TetR) and development of zygote inhibited (DOZI) fusion protein to generate TetR-DOZI conditional system. (b) PCR analysis confirmed integration at the recombinant locus. Wild type parasites were detected using primers P8-P2 for PfPPRD and P17-P11 for PfCPT (see Supplementary Table S1 ) after 4 days of transfection (A'). Conditional knockdown parasites were detected after 30 days post-transfection (B') using primers P8-P9 for PfPPRD and P17-P9 for PfCPT. . 13 C-Enrichment due to de novo biosynthesis in the PfPPRD mutant strain was observed for polyprenol 18 in P. falciparum after 10 days aTc was removed (a) while 13 C-enrichment was undetectable for dolichol 18 (b) supporting that PfPPRD enzymatic activity is negligible. Metabolic labeling with [1-13 C]glucose was performed as indicated in Fig. 3a (scheme) and as described in the methodology section. Natural isotopic distribution for polyprenol (POH) and dolichol (DOH) is indicated for the standard. 13 
